Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders

BACKGROUND: Immunoglobulin therapy plays a critical role in the treatment of immunodeficiency disorders as well as autoimmune and inflammatory conditions. In immunodeficient patients, there has been controversy whether initial loading doses of intravenous (IVIG) should be based on actual body weight...

Descripción completa

Detalles Bibliográficos
Autor principal: Ameratunga, Rohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718066/
https://www.ncbi.nlm.nih.gov/pubmed/29225631
http://dx.doi.org/10.1186/s13223-017-0220-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718066/
https://www.ncbi.nlm.nih.gov/pubmed/29225631
http://dx.doi.org/10.1186/s13223-017-0220-y

Ejemplares similares